Bacterial meningitis primary prevention: Difference between revisions

Jump to navigation Jump to search
Line 7: Line 7:
Primary preventive measures to prevent bacterial meningitis include the following
Primary preventive measures to prevent bacterial meningitis include the following
===Vaccination===
===Vaccination===
There are three types of vaccination available for prevention of bacterial meningitis from three bacterial agents. These include:
There are three types of vaccination available for prevention of bacterial meningitis from three bacterial agents. These include:<ref name="pmid23515099">{{cite journal| author=Cohn AC, MacNeil JR, Clark TA, Ortega-Sanchez IR, Briere EZ, Meissner HC et al.| title=Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). | journal=MMWR Recomm Rep | year= 2013 | volume= 62 | issue= RR-2 | pages= 1-28 | pmid=23515099 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23515099  }} </ref><ref name="pmid26845283">{{cite journal| author=Robinson CL, Advisory Committee on Immunization Practices (ACIP), ACIP Child/Adolescent Immunization Work Group| title=Advisory Committee on Immunization Practices Recommended Immunization Schedules for Persons Aged 0 Through 18 Years--United States, 2016. | journal=MMWR Morb Mortal Wkly Rep | year= 2016 | volume= 65 | issue= 4 | pages= 86-7 | pmid=26845283 | doi=10.15585/mmwr.mm6504a4 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26845283  }} </ref><ref name="pmid17447825">{{cite journal| author=Makwana N, Riordan FA| title=Bacterial meningitis: the impact of vaccination. | journal=CNS Drugs | year= 2007 | volume= 21 | issue= 5 | pages= 355-66 | pmid=17447825 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17447825  }} </ref><ref name="pmid24432035">{{cite journal| author=English P| title=Vaccination against meningitis B: is it worth it? | journal=Drugs Context | year= 2013 | volume= 2013 | issue=  | pages= 212246 | pmid=24432035 | doi=10.7573/dic.212246 | pmc=3884741 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24432035  }} </ref>


{| style="border: 0px; font-size: 90%; margin: 3px;" align=center
{| style="border: 0px; font-size: 90%; margin: 3px;" align=center

Revision as of 16:32, 5 January 2017

Meningitis main page

Bacterial meningitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Meningitis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Lumbar Puncture

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aysha Anwar, M.B.B.S[2]

Overview

Primary prevention

Primary preventive measures to prevent bacterial meningitis include the following

Vaccination

There are three types of vaccination available for prevention of bacterial meningitis from three bacterial agents. These include:[1][2][3][4]

Vaccinations
Type of Vaccination Recommendations
Pneumococcal[5]
  • Pneumococcal conjugate vaccine(PCV13)
  • Pneumococcal polysaccharide vaccine(PPSV23)

Pneumococcal conjugate vaccine

  • Children under 2 years of age
  • Older people >65 years of age
  • Individuals 2 to 65 years of with medical conditions such as patients with CKD, cochlear implants, asplenia

Pneumococcal polysaccharide vaccine

  • All adults 65 years or older
  • People 2 to 65 years with certain medical conditions such as diabetes and chronic heart, lung or liver disease
  • Adults 19 to 64 years who smoke cigarettes
Meningococcal[6]
  • Meningococcal conjugate vaccines
  • Meningococcal polysaccharide vaccine
  • Serogroup B meningococcal vaccines
  • Children and adolescents age 11 through 18
  • Military recruits
  • College students living in dorms
  • Splenectomy or splenic damage
  • Person having complement deficiency
  • People travelling to endemic areas such as Africa
Hemophilus influenza type b (Hib)[7]
  • All children younger than 5 years of age
  • People at increased risk of invasive hib infection such as asplenia, HIV infection
  • Unvaccinated older individuals or adults with medical conditions [8]

Other preventive measures

Other preventive measures
Preventive strategy Recommendations
Avoidance of risk factors
Droplet precaution
  • People exposed to patients within three to six feet of the patient should wear surgical mask
  • Doors of the room where patient resides should be kept open
Chemoprophylaxis
  • Chemopropylaxis required for suspected or confirmed cases of meningococcal infection
  • All household members
  • Roomates or intimate contacts
  • Child care workers
  • People directly exposed to patient's respiratory or oral secretions
  • Airline travelers seated close to affected person > 8 hours

References

  1. Cohn AC, MacNeil JR, Clark TA, Ortega-Sanchez IR, Briere EZ, Meissner HC; et al. (2013). "Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP)". MMWR Recomm Rep. 62 (RR-2): 1–28. PMID 23515099.
  2. Robinson CL, Advisory Committee on Immunization Practices (ACIP), ACIP Child/Adolescent Immunization Work Group (2016). "Advisory Committee on Immunization Practices Recommended Immunization Schedules for Persons Aged 0 Through 18 Years--United States, 2016". MMWR Morb Mortal Wkly Rep. 65 (4): 86–7. doi:10.15585/mmwr.mm6504a4. PMID 26845283.
  3. Makwana N, Riordan FA (2007). "Bacterial meningitis: the impact of vaccination". CNS Drugs. 21 (5): 355–66. PMID 17447825.
  4. English P (2013). "Vaccination against meningitis B: is it worth it?". Drugs Context. 2013: 212246. doi:10.7573/dic.212246. PMC 3884741. PMID 24432035.
  5. https://www.cdc.gov/vaccines/hcp/vis/vis-statements/pcv13.html, Accessed on Jan 5, 2017
  6. https://www.cdc.gov/meningococcal/vaccine-info.html, Accessed on 5th Jan, 2017
  7. https://www.cdc.gov/vaccines/hcp/vis/vis-statements/hib.html, Accessed on 5th Jan, 2017
  8. https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6301a1.htm, Accessed on 5th Jan, 2017


Template:WikiDoc Sources